- Home
- CEPU vs KYMR Comparison
CEPU vs KYMR Comparison
Compare CEPU & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- KYMR
- Stock Information
- Founded
- CEPU 1989
- KYMR 2015
- Country
- CEPU Argentina
- KYMR United States
- Employees
- CEPU N/A
- KYMR N/A
- Industry
- CEPU Electric Utilities: Central
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CEPU Utilities
- KYMR Health Care
- Exchange
- CEPU Nasdaq
- KYMR Nasdaq
- Market Cap
- CEPU 1.6B
- KYMR 1.8B
- IPO Year
- CEPU 2018
- KYMR 2020
- Fundamental
- Price
- CEPU $13.03
- KYMR $29.64
- Analyst Decision
- CEPU Hold
- KYMR Buy
- Analyst Count
- CEPU 1
- KYMR 15
- Target Price
- CEPU $12.00
- KYMR $55.47
- AVG Volume (30 Days)
- CEPU 366.8K
- KYMR 650.3K
- Earning Date
- CEPU 05-12-2025
- KYMR 05-09-2025
- Dividend Yield
- CEPU 2.38%
- KYMR N/A
- EPS Growth
- CEPU N/A
- KYMR N/A
- EPS
- CEPU 0.06
- KYMR N/A
- Revenue
- CEPU $697,204,690.00
- KYMR $58,885,000.00
- Revenue This Year
- CEPU $26.57
- KYMR $32.80
- Revenue Next Year
- CEPU N/A
- KYMR $8.88
- P/E Ratio
- CEPU $22.04
- KYMR N/A
- Revenue Growth
- CEPU N/A
- KYMR N/A
- 52 Week Low
- CEPU $7.07
- KYMR $19.45
- 52 Week High
- CEPU $16.60
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- CEPU 56.54
- KYMR 48.27
- Support Level
- CEPU $13.07
- KYMR $28.06
- Resistance Level
- CEPU $13.65
- KYMR $30.28
- Average True Range (ATR)
- CEPU 0.69
- KYMR 1.65
- MACD
- CEPU 0.02
- KYMR -0.19
- Stochastic Oscillator
- CEPU 52.99
- KYMR 27.96
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.